Jinen Song
-
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
- Pancreatic and Hepatic Oncology Research 2
-
- Immunotherapy and Immune Responses 2
- Immune cells in cancer 2
-
- Melanoma and MAPK Pathways 3
- Single-cell and spatial transcriptomics 2
-
- Thyroid and Parathyroid Surgery 2
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Advanced Functional Materials (1 paper)Cancer Cell (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jinen Song
14 papers receiving 436 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 222
- Immunology 157
- Cancer Research 92
- Molecular Biology 159
- Molecular Medicine 10
Countries citing papers authored by Jinen Song
This map shows the geographic impact of Jinen Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinen Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinen Song more than expected).
Fields of papers citing papers by Jinen Song
This network shows the impact of papers produced by Jinen Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinen Song. The network helps show where Jinen Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinen Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillancebreakdown → | 2023 | 217 |
| 3 | 2023 | 4 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 47 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 23 | |
| 11 | 2019 | 31 | |
| 12 | 2019 | 33 | |
| 13 | 2018 | 19 | |
| 14 | 2015 | 2 |
About Jinen Song
Jinen Song is a scholar working on Oncology, Cancer Research and Immunology, having authored 14 papers that have together received 439 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Melanoma and MAPK Pathways (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Single-cell and spatial transcriptomics (2 papers), Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers) and Thyroid and Parathyroid Surgery (2 papers). The work is most often cited by research in Oncology (222 citations), Immunology (157 citations) and Cancer Research (92 citations). Jinen Song has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hubing Shi, Xuelei Ma, Xiaowei Liu, Yujie Zhao, Xi Wu, Jing Jing, Hu Zhang, Xinyu Guo, Hao Zhang and Xinyu Liu. Their work appears in journals such as Advanced Functional Materials, Cancer Cell and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.